Full Issue

Individual Articles - Sep/Oct 2022 - Volume 26, Number 5

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2022 Pg. 356	PreScription: A New Dosage Form Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 358-362	Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Author(s): Lopez C Vidal, Rios GL Quito
Sep/Oct 2022 Pg. 364-368	A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Author(s): Riepl Mike
Sep/Oct 2022 Pg. 370-377	Recent Formulation Advances and Preparation of Orally Disintegrating Tablets Author(s): Ejeta Fikadu
Sep/Oct 2022 Pg. 378-384	Compounded Medications and Probiotics for Irritable Bowel Syndrome Author(s): Narváez Katherine Rivera, Thompson Tara
Sep/Oct 2022 Pg. 385-395	Compounding with Biotechnology Products, Part 1: General Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 396-398	The FDA is in a Hole. It Should Stop Digging. Author(s): Brunner Scott
Sep/Oct 2022 Pg. 400-408	Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 411-418	Sterile Basics of Compounding: Contamination Control Strategies, Part 1 Author(s): Summers Amy
Sep/Oct 2022 Pg. 420	Calculations Author(s): Stockton Shelly J
Sep/Oct 2022 Pg. 422	Amphotericin B 3% Otic Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 423	Ascorbic acid 5% Topical Microemulsion Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 424	Chlorhexidine Diacetate 2% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 425	Clindamycin Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 426	Clotrimazole 10-mg Troches Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 427	Cysteamine Hydrochloride 100 mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 428	Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 429	Lansoprazole 3-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 430	Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 431	Methylcobalamin 2-mg/mL Nasal Spray Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 432-435	Effectiveness of a New Ultraviolet C Disinfection System to Inactivate Airborne Coronavirus in Different Environmental Conditions Author(s): Marianni Bruna, Polonini Hudson
Sep/Oct 2022 Pg. 436-439	Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease Author(s): Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo